LONNA WILLIAMS: Open Payments
NPI 1851390918 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,779 in 87 payments from 17 companies in 2025. Trend: 2023 $652 · 2024 $1,312 · 2025 $1,779
Food & beverage: $1,707Education: $72
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $309 |
| Novartis Pharmaceuticals Corporation | 16 | $216 |
| Amgen Inc. | 11 | $194 |
| AstraZeneca Pharmaceuticals LP | 9 | $159 |
| E.R. Squibb & Sons, L.L.C. | 4 | $151 |
| Merck Sharp & Dohme LLC | 9 | $138 |
| BridgeBio Pharma, Inc. | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $89 |
| Boston Scientific Corporation | 4 | $87 |
| Actelion Pharmaceuticals US, Inc. | 1 | $72 |
Products named: LEQVIO, FARXIGA, CAMZYOS, Wegovy, VERQUVO, Attruby, JARDIANCE, WATCHMAN FLX.
Industry payments across IN — which companies pay providers there.
